Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Sarcoma and Rare Cancers Congress 2025

Optimal sequence in G2-G3 pancreatic neuroendocrine tumour (NET)

Q&A and discussion

Date

22 Mar 2025

Session

Optimal sequence in G2-G3 pancreatic neuroendocrine tumour (NET)

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Case presentation

Presenter: Rachel Riechelmann

Session: Optimal sequence in G2-G3 pancreatic neuroendocrine tumour (NET)

Resources:

Slides

Webcast

Chemotherapy first

Presenter: Teresa Alonso Gordoa

Session: Optimal sequence in G2-G3 pancreatic neuroendocrine tumour (NET)

Resources:

Slides

Webcast

Other treatment options

Presenter: Rachel Riechelmann

Session: Optimal sequence in G2-G3 pancreatic neuroendocrine tumour (NET)

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.